Efficient Maternofetal Transplacental Transfer of Anti- Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Spike Antibodies after Antenatal SARS-CoV-2 BNT162b2 Messenger RNA Vaccination

Amihai Rottenstreich; Gila Zarbiv; Esther Oiknine-Djian; Roy Zigron; Dana G. Wolf; Shay Porat

doi:10.1093/cid/ciab266

Efficient Maternofetal Transplacental Transfer of Anti- Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Spike Antibodies after Antenatal SARS-CoV-2 BNT162b2 Messenger RNA Vaccination

Amihai Rottenstreich, Gila Zarbiv, Esther Oiknine-Djian, Roy Zigron, Dana G. Wolf, Shay Porat

Research output: Contribution to journal › Article › peer-review

62 Scopus citations

Abstract

Maternal and cord blood sera were collected from 20 parturients who received the BNT162b2 vaccine. All women and infants were positive for anti S- and anti-receptor binding domain antibody-specific immunoglobulin G. Cord blood antibody concentrations were correlated to maternal levels and to time since vaccination. Antenatal severe acute respiratory syndrome coronavirus 2 vaccination may provide maternal and neonatal protection.

Original language	English
Pages (from-to)	1909-1912
Number of pages	4
Journal	Clinical Infectious Diseases
Volume	73
Issue number	10
DOIs	https://doi.org/10.1093/cid/ciab266
State	Published - 15 Nov 2021
Externally published	Yes

Keywords

Cord blood
Pregnancy
SARS-CoV-2
Serology
Vaccination

ASJC Scopus subject areas

Microbiology (medical)
Infectious Diseases

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1093/cid/ciab266

Cite this

Rottenstreich, A., Zarbiv, G., Oiknine-Djian, E., Zigron, R., Wolf, D. G., & Porat, S. (2021). Efficient Maternofetal Transplacental Transfer of Anti- Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Spike Antibodies after Antenatal SARS-CoV-2 BNT162b2 Messenger RNA Vaccination. Clinical Infectious Diseases, 73(10), 1909-1912. https://doi.org/10.1093/cid/ciab266

@article{72684e1142474346b7512d013e5aa00c,

title = "Efficient Maternofetal Transplacental Transfer of Anti- Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Spike Antibodies after Antenatal SARS-CoV-2 BNT162b2 Messenger RNA Vaccination",

abstract = "Maternal and cord blood sera were collected from 20 parturients who received the BNT162b2 vaccine. All women and infants were positive for anti S- and anti-receptor binding domain antibody-specific immunoglobulin G. Cord blood antibody concentrations were correlated to maternal levels and to time since vaccination. Antenatal severe acute respiratory syndrome coronavirus 2 vaccination may provide maternal and neonatal protection.",

keywords = "Cord blood, Pregnancy, SARS-CoV-2, Serology, Vaccination",

author = "Amihai Rottenstreich and Gila Zarbiv and Esther Oiknine-Djian and Roy Zigron and Wolf, {Dana G.} and Shay Porat",

year = "2021",

month = nov,

day = "15",

doi = "10.1093/cid/ciab266",

language = "English",

volume = "73",

pages = "1909--1912",

journal = "Clinical Infectious Diseases",

issn = "1058-4838",

publisher = "Oxford University Press",

number = "10",

}

Rottenstreich, A, Zarbiv, G, Oiknine-Djian, E, Zigron, R, Wolf, DG & Porat, S 2021, 'Efficient Maternofetal Transplacental Transfer of Anti- Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Spike Antibodies after Antenatal SARS-CoV-2 BNT162b2 Messenger RNA Vaccination', Clinical Infectious Diseases, vol. 73, no. 10, pp. 1909-1912. https://doi.org/10.1093/cid/ciab266

Efficient Maternofetal Transplacental Transfer of Anti- Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Spike Antibodies after Antenatal SARS-CoV-2 BNT162b2 Messenger RNA Vaccination. / Rottenstreich, Amihai; Zarbiv, Gila; Oiknine-Djian, Esther et al.
In: Clinical Infectious Diseases, Vol. 73, No. 10, 15.11.2021, p. 1909-1912.

Research output: Contribution to journal › Article › peer-review

TY - JOUR

T1 - Efficient Maternofetal Transplacental Transfer of Anti- Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Spike Antibodies after Antenatal SARS-CoV-2 BNT162b2 Messenger RNA Vaccination

AU - Rottenstreich, Amihai

AU - Zarbiv, Gila

AU - Oiknine-Djian, Esther

AU - Zigron, Roy

AU - Wolf, Dana G.

AU - Porat, Shay

PY - 2021/11/15

Y1 - 2021/11/15

N2 - Maternal and cord blood sera were collected from 20 parturients who received the BNT162b2 vaccine. All women and infants were positive for anti S- and anti-receptor binding domain antibody-specific immunoglobulin G. Cord blood antibody concentrations were correlated to maternal levels and to time since vaccination. Antenatal severe acute respiratory syndrome coronavirus 2 vaccination may provide maternal and neonatal protection.

AB - Maternal and cord blood sera were collected from 20 parturients who received the BNT162b2 vaccine. All women and infants were positive for anti S- and anti-receptor binding domain antibody-specific immunoglobulin G. Cord blood antibody concentrations were correlated to maternal levels and to time since vaccination. Antenatal severe acute respiratory syndrome coronavirus 2 vaccination may provide maternal and neonatal protection.

KW - Cord blood

KW - Pregnancy

KW - SARS-CoV-2

KW - Serology

KW - Vaccination

UR - http://www.scopus.com/inward/record.url?scp=85121204281&partnerID=8YFLogxK

U2 - 10.1093/cid/ciab266

DO - 10.1093/cid/ciab266

M3 - Article

C2 - 33822014

AN - SCOPUS:85121204281

SN - 1058-4838

VL - 73

SP - 1909

EP - 1912

JO - Clinical Infectious Diseases

JF - Clinical Infectious Diseases

IS - 10

ER -

Efficient Maternofetal Transplacental Transfer of Anti- Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Spike Antibodies after Antenatal SARS-CoV-2 BNT162b2 Messenger RNA Vaccination

Abstract

Keywords

ASJC Scopus subject areas

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this